$AME

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.

Original reporting
Published Aug 15, 2026, 11:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 16, 2026, 5:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMETEK Raises 2026 Outlook After Earnings Climb 17% — source image
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The company’s raised 2026 adjusted EPS range and higher sales growth expectation are the core tradable catalysts, reinforced by record segment sales, margin expansion, and stronger operating cash flow.

02

Market read

A concrete earnings and sales guidance increase, backed by strong orders and margin expansion, is likely to drive earnings-expectations revisions and near-term momentum trading.

03

What to watch

Acquisition contribution is cited; investors may discount organic durability and watch for any post-acquisition integration or demand normalization.

Relevance 9/10Novelty 9/10Timing: after-hours or next-session repricing following the 2026 outlook raise

Background

AMETEK reported Q2 results and then updated its full-year 2026 outlook, citing stronger orders and operating performance.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK raised its 2026 adjusted EPS outlook to $8.20 to $8.30 after Q2 adjusted profit rose 17% and orders jumped 28%.

Expected impact

Likely near-term positive bias as traders reprice 2026 earnings expectations; follow-through depends on whether Q3 sales and EPS guidance holds.

Evidence & confidence

The article provides specific, time-sensitive forecast numbers (full-year EPS range and Q3 EPS range) tied to reported Q2 results (sales, orders, margins, cash flow).

Market effects

Supports the narrative of continued strength in industrial instrumentation and test/measurement demand tied to semiconductors, aerospace, defense, and automation.

Primarily US large-cap industrials sentiment; limited direct regional spillover beyond industrial cyclicals.

Signals ongoing capex and maintenance demand trends that can influence global industrial electronics and instrumentation peers’ sentiment.

Counterpoint

The guidance raise may already be partially priced, and the key risk is whether order strength converts into sustained margins and cash flow in later quarters.

Key entities

  • AMETEK Inc.

    Industrial technology company raising 2026 adjusted earnings outlook after Q2 profit and orders outperformance.

  • David A. Zapico

    Chairman and CEO who attributed the outlook raise to strong organic sales, acquisitions, and operating performance.

Related articles

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK (AME) Q2 2026 Earnings Call Transcript

AMETEK (AME) reported Q2 2026 net sales of $2.04B, up 15% year over year, with 10% organic growth. Adjusted EPS was $2.09, up 17%, above guidance of $1.96 to $2.00. Total orders were $2.3B, up 28%, backlog $4.11B. Full-year sales guidance rose about 10% and adjusted EPS to $8.20-$8.30.

$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.

$AMEHigh

AMETEK INC/ (AME): Results of Operations and Financial Condition

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ametek8kexhibit99108042026.htm EX-99.1 Document Exhibit 99.1 AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Aug 4, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30,

$AMEMedAI 8/10

AMETEK’s (NYSE:AME) Q2 CY2026: Strong Sales

AMETEK (NYSE:AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year on year, exceeding Wall Street estimates by 4.4%, according to the company. Non-GAAP adjusted EPS was $2.09, up from $1.78 and 4.8% above consensus. Analysts expect full-year EPS of $8.46, up from $7.96.